SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-005537
Filing Date
2019-04-01
Accepted
2019-04-01 17:12:05
Documents
82
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_wizepharmainc.htm 10-K 1642569
2 MEMORANDUM OF UNDERSTANDING BETWEEN WIZE PHARMA LTD. AND RESDEVCO, RESEARCH AND f10k2018ex10-57_wizepharma.htm EX-10.57 8552
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2018ex23-1_wizephara.htm EX-23.1 3949
4 CERTIFICATION f10k2018ex31-1_wizepharma.htm EX-31.1 14109
5 CERTIFICATION f10k2018ex31-2_wizepharma.htm EX-31.2 13025
6 CERTIFICATION f10k2018ex32-1_wizepharma.htm EX-32.1 6778
7 CERTIFICATION f10k2018ex32-2_wizepharma.htm EX-32.2 6907
8 GRAPHIC img_01.jpg GRAPHIC 12438
15 GRAPHIC ex23-1_001.jpg GRAPHIC 16305
  Complete submission text file 0001213900-19-005537.txt   6564718

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE wizp-20181231.xml EX-101.INS 1180318
10 XBRL SCHEMA FILE wizp-20181231.xsd EX-101.SCH 64786
11 XBRL CALCULATION FILE wizp-20181231_cal.xml EX-101.CAL 25197
12 XBRL DEFINITION FILE wizp-20181231_def.xml EX-101.DEF 177209
13 XBRL LABEL FILE wizp-20181231_lab.xml EX-101.LAB 513868
14 XBRL PRESENTATION FILE wizp-20181231_pre.xml EX-101.PRE 345765
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52545 | Film No.: 19721739
SIC: 2834 Pharmaceutical Preparations